Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 57
Filter
1.
Health Qual Life Outcomes ; 18(1): 245, 2020 Jul 22.
Article in English | MEDLINE | ID: mdl-32698883

ABSTRACT

BACKGROUND: Literature on the validity of outcome measurement in lymphedema and lipedema is very sparse. This study aimed to examine the convergent, divergent and discriminant validity of a set of 5 instruments in both conditions. METHODS: Cross-sectional outcome was measured by the generic Short Form 36 (SF-36), the lymphedema-specific Freiburg Quality of Life Assessment for lymphatic disorders, Short Version (FLQA-lk), the knee-specific Knee Outcome Survey Activities of Daily Living Scale (KOS-ADL), the Symptom Checklist-90-revised (SCL-90R), and the Six-Minute Walk Test (6 MWT). Construct convergent/divergent validity was quantified by bivariate correlations and multivariate factor analysis, and discriminant validity by standardized mean differences (SMDs). RESULTS: Health was consistently better in lymphedema (n = 107) than in lipedema (n = 96). The highest construct convergence was found for physical health between the SF-36 and KOS-ADL (bivariate correlations up to 0.78, factor loads up to 0.85, explained variance up to 56.8%). The second most important factor was mental health (bivariate correlations up to 0.79, factor loads up to 0.86, explained variance up to 13.3%). Discriminant validity was greatest for the FLQA-lk Physical complaints (adjusted SMD = 0.93) followed by the SF-36 Bodily pain (adjusted SMD = 0.83), KOS-ADL Function (adjusted SMD = 0.47) and SF-36 Vitality (adjusted SMD = 0.39). CONCLUSIONS: All five instruments have specific strengths and can be implemented according to the scope and aim of the outcome examination. A minimum measurement set should comprise: the SF-36 Bodily pain, SF-36 Vitality, FLQA-lk Physical complaints, FLQA-lk Social life, FLQA-lk Emotional well-being, FLQA-lk Health state, KOS-ADL Symptoms, KOS-ADL Function, and the SCL-90R Interpersonal sensitivity.


Subject(s)
Lipedema/psychology , Lymphedema/psychology , Quality of Life , Surveys and Questionnaires/standards , Adult , Aged , Cross-Sectional Studies , Female , Humans , Lower Extremity/physiopathology , Male , Middle Aged , Reproducibility of Results
2.
Praxis (Bern 1994) ; 108(8): 517, 2019 Jun.
Article in German | MEDLINE | ID: mdl-31185848
3.
4.
J Rehabil Med ; 51(2): 127-135, 2019 Feb 01.
Article in English | MEDLINE | ID: mdl-30667513

ABSTRACT

OBJECTIVE: To quantify and compare the course of health-related quality of life of immigrant native Italian-speaking and German-speaking patients before and after an interdisciplinary pain programme. DESIGN: Prospective cohort study with 1-12 month follow-up. SUBJECTS: Fibromyalgia, generalized widespread pain, and chronic non-specific back pain patients (Italian-speaking n = 96, German-speaking n = 199). METHODS: Score changes measured with the Short Form 36 (SF-36) were compared with multivariate analysis using standardized mean differences (SMD), adjusted for sex, education and the baseline score. RESULTS: At baseline, health of the Italian-speaking patients was worse than for the German-speaking patients. Adjusted SMDs showed significantly better improvements in the German group compared with the Italian group: SF-36 Physical functioning SMD = 0.54 (at discharge) and 0.49 (at 12 months), General health SMD = 0.71 and 0.44, Vitality SMD = 0.43 and 0.48 in one sample. In the other sample, the corresponding SMDs were 0.06 (discharge), 0.50 (3 months) and 0.47 (6 months) for Bodily pain. CONCLUSION: State of health was better and health improvements were greater in German-speaking patients compared with Italian-speaking patients. Patients with a migration background may have special needs in therapeutic management, and addressing these might enhance the positive outcome in the short- and mid-term.


Subject(s)
Pain Management/methods , Pain/rehabilitation , Quality of Life/psychology , Cohort Studies , Female , Humans , Language , Male , Middle Aged , Prospective Studies , Switzerland
5.
RMD Open ; 4(2): e000685, 2018.
Article in English | MEDLINE | ID: mdl-30402264

ABSTRACT

OBJECTIVE: To determine minimal clinically important differences (MCIDs) for improvement and worsening in various health dimensions in knee osteoarthritis under conservative therapy. METHODS: Health, symptoms and function were assessed by the generic Short Form 36 and the condition-specific Western Ontario and McMaster Universities Osteoarthritis Index in n=190 patients with knee osteoarthritis before and after comprehensive rehabilitation intervention (3-month follow-up). By means of construct-specific transition questions, MCIDs were defined as the difference between the 'slightly better/worse' and the 'almost equal' transition response categories according to the 'mean change method'. The bivariate MCIDs were adjusted for sex, age and baseline score to obtain adjusted MCIDs by multivariate linear regression. They were further standardised as (baseline) effect sizes (ESs), standardised response means (SRMs) and standardised mean differences (SMDs) and compared with the minimal detectable change with 95% confidence (MDC95). RESULTS: Multivariate, adjusted MCIDs for improvement ranged from 2.89 to 16.24 score points (scale 0-100), corresponding to ES=0.14 to 0.63, SRM=0.17 to 0.61 and SMD=0.18 to 0.72. The matching results for worsening were -5.80 to -12.68 score points, ES=-0.30 to -0.56, SRM=-0.35 to -0.52 and SMD=-0.35 to -0.58. Almost all MCIDs were larger than the corresponding MDC95s. CONCLUSIONS: This study presents MCIDs quantified according to different methods over a comprehensive range of health dimensions. In most health dimensions, multivariate adjustment led to higher symmetry between the MCID levels of improvement and worsening. MCIDs expressed as standardised effect sizes (ES, SRM, SMD) and adjusted by potential confounders facilitate generalisation to the results of other studies.

6.
Health Qual Life Outcomes ; 16(1): 42, 2018 Mar 09.
Article in English | MEDLINE | ID: mdl-29523138

ABSTRACT

BACKGROUND: The Migraine Disability Assessment (MIDAS) is a brief questionnaire and measures headache-related disability. This study aimed to translate and cross-culturally adapt the original English version of the MIDAS to German and to test its reliability. METHODS: The standardized translation process followed international guidelines. The pre-final version was tested for clarity and comprehensibility by 34 headache sufferers. Test-retest reliability of the final version was quantified by 36 headache patients completing the MIDAS twice with an interval of 48 h. Reliability was determined by intraclass correlation coefficients and internal consistency by Cronbach's α. RESULTS: All steps of the translation process were followed, documented and approved by the developer of the MIDAS. The expert committee discussed in detail the complex phrasing of the questions that refer to one to another, especially exclusion of headache-days from one item to the next. The German version contains more active verb sentences and prefers the perfect to the imperfect tense. The MIDAS scales intraclass correlation coefficients ranged from 0.884 to 0.994 and was 0.991 (95% CI: 0.982-0.995) for the MIDAS total score. Cronbach's α for the MIDAS as a whole was 0.69 at test and 0.67 at retest. CONCLUSIONS: The translation process was challenged by the comprehensibility of the questionnaire. The German version of the MIDAS is a highly reliable instrument for assessing headache related disability with moderate internal consistency. Provided validity testing of the German MIDAS is successful, it can be recommended for use in clinical practice as well as in research.


Subject(s)
Cross-Cultural Comparison , Disability Evaluation , Migraine Disorders/physiopathology , Surveys and Questionnaires/standards , Translations , Adult , Aged , Female , Humans , Male , Middle Aged , Quality of Life , Reproducibility of Results
7.
BMC Gastroenterol ; 18(1): 21, 2018 Jan 27.
Article in English | MEDLINE | ID: mdl-29374473

ABSTRACT

BACKGROUND: Although subacute and chronic gastrointestinal symptoms are very common in primary care, epidemiological date are sparse. The aim of the study was to examine and quantify the prevalence of subacute and chronic gastrointestinal symptoms and their associations with somatic and mental disorders in the general population. METHODS: Data were collected prospectively between 1981 (age m = 22, f = 23) and 2008 (age 49/50) from the Zurich Cohort Study (n = 292 men, 299 women), a representative general population survey. The participants were assessed using a semi-structured interview, the "Structured Psychopathological Interview and Rating of the Social Consequences of Psychological Disturbances for Epidemiology" (SPIKE). Prevalence rates were computed to be representative of the general population aged 22-50. Associations were quantified by odds ratios (ORs) and their 99% confidence intervals (CI). RESULTS: The prevalences of intestinal and of gastric symptoms were significantly higher among women in all categories examined. For example, any gastric symptoms: f. 26.4% vs m.15.2%; any intestinal symptoms: 27.6% vs 14.6%; nausea/vomitus: 19.1% vs 4.5%; constipation: 15.8% vs 6.5% (all p < 0.001). Strong associations (all p < 0.0001) were found between fatigue (1 month) and chronic stomach (OR = 9.96, 99%-CI: 5.53-17.94) and chronic intestinal symptoms (OR = 9.02, 99%-CI: 4.92-16.54). Panic attacks were associated with subacute intestinal symptoms (OR = 4.00, 99%-CI: 2.43-6.59). Anxiety was more strongly associated with subacute intestinal symptoms (OR = 3.37, 99%-CI: 2.23-5.08) than with subacute stomach symptoms (OR = 1.85, 1.20-2.86). Bipolar disorders were associated with subacute stomach symptoms (OR = 1.83, 1.18-2.17) and unipolar depression with subacute intestinal symptoms (OR = 2.05, 1.34-3.15). CONCLUSIONS: Remarkably high prevalence rates of gastric and intestinal complaints were observed in women (over 1/4; men 1/7). Fatigue/neurasthenia was the strongest co-factor in both conditions. Various syndromes related to anxiety, phobia, and panic disorders showed further significant associations. The integration of psychiatric and/or psychological treatment could help address the functional part of gastric and intestinal syndromes.


Subject(s)
Gastrointestinal Diseases/epidemiology , Gastrointestinal Diseases/psychology , Mental Disorders/epidemiology , Adult , Anxiety/epidemiology , Bipolar Disorder/epidemiology , Comorbidity , Depression/epidemiology , Fatigue/epidemiology , Female , Humans , Male , Middle Aged , Panic Disorder/epidemiology , Prevalence , Sex Distribution , Switzerland/epidemiology , Young Adult
8.
Eur J Phys Rehabil Med ; 54(3): 358-370, 2018 Jun.
Article in English | MEDLINE | ID: mdl-28849895

ABSTRACT

BACKGROUND: Prospective classification of patients with nonspecific chronic back pain into homogeneous subgroups might be an important objective in order to tailor interventions and improve treatment outcomes. AIM: This study investigated the effect of a subgroup-specific pain rehabilitation program based on the Multidimensional Pain Inventory (MPI) Classification System compared to standard care. DESIGN: Single blinded, parallel group, pragmatic randomized controlled trial. SETTING: Inpatient subjects of a rehabilitation clinic. POPULATION: A total of 139 patients with chronic back pain. METHODS: Patients in both the experimental group and control group received during their 4-week in-house stay at the rehabilitation clinic on average four daily sessions of therapy. The patients in the experimental group received specific interventions, which were tailored to their subgroup classification profile. The patients in the control group participated in state-of-the-art care. The primary outcome was self-reported disability measured at 1, 3 and 12 months after randomization with the Oswestry Disability Index (ODI). Secondary outcomes were pain intensity, examiner-reported disability, anxiety and depression, catastrophizing, self-efficacy and global perceived effect. RESULTS: Groups were comparable under demographic and clinical characteristics. No significant differences between the experimental group and the control group for any of the outcomes and follow-up times were found in the intention-to-treat analysis. Compared to the 8-10 points considered as minimal clinically important difference for the ODI, effects within groups were small, e.g. the experimental group improved by 2.2 points at 1-month follow-up, 3.7 points at 3 months and 5.3 points at 12 months. CONCLUSIONS: This study failed to demonstrate that a subgroup-specific program was more effective than standard care. CLINICAL REHABILITATION IMPACT: Since the subgroup-specific interventions were equally effective as standard pain rehabilitation, subgroup classification and tailoring interventions may be an alternative in clinical care.


Subject(s)
Back Pain/rehabilitation , Chronic Pain/rehabilitation , Disability Evaluation , Pain Management/methods , Physical Therapy Modalities , Adult , Aged , Back Pain/diagnosis , Chronic Pain/diagnosis , Female , Follow-Up Studies , Humans , Inpatients , Male , Middle Aged , Netherlands , Prospective Studies , Rehabilitation Centers , Risk Assessment , Single-Blind Method , Time Factors , Treatment Outcome , Young Adult
9.
Psychosomatics ; 58(6): 604-613, 2017.
Article in English | MEDLINE | ID: mdl-28867433

ABSTRACT

BACKGROUND: Back pain is extremely common and a huge burden for both individuals and health care services. OBJECTIVE: The aim was to determine the prevalence and incidence of lumbar and cervical back pain over 23 years and to quantify associations with concomitant disorders. METHODS: Data on lumbar and cervical back pain, and mental disorders from the Zurich study, collected between 1986 (age men: 27/women: 28 years) and 2008 (age 49/50) were analyzed. Epidemiological parameters were representative rates for the general population. Associations were quantified by odds ratios (ORs). RESULTS: Of 499 subjects, 68.9% ever experienced lumbar pain and 60.7% ever experienced cervical back pain; the 23-year prevalences were 66.9% and 54.9% and the 23-year incidences 52.3% and 48.9% for lumbar and cervical back pain, respectively. Annual prevalences varied between 28.4% and 47.2% for lumbar and 18.3% and 54.7% for cervical back pain; the corresponding annual incidences varied by 5.8-13.3% (lumbar) and 7.8-12.6% (cervical). Lumbar back pain was significantly associated with cardiovascular disease (OR = 4.58), obesity (OR = 3.99), asthma spectrum (OR = 5.76), tranquillizer dependence (OR = 5.84), and other comorbidities (ORs = 1.47-3.27). Significant associations with cervical back pain were observed for specific phobia (OR = 5.10), panic attacks (OR = 4.79), and other comorbidities (ORs = 1.61-2.62). CONCLUSIONS: This study contributes to the refinement of epidemiological data on lumbar and cervical back pain. Some associations with treatable disorders were high, which may offer hope for the indirect management of lumbar and cervical back pain.


Subject(s)
Low Back Pain/epidemiology , Neck Pain/epidemiology , Panic Disorder/epidemiology , Phobic Disorders/epidemiology , Substance-Related Disorders/epidemiology , Adult , Asthma/epidemiology , Back Pain/epidemiology , Cardiovascular Diseases/epidemiology , Cohort Studies , Comorbidity , Female , Humans , Incidence , Longitudinal Studies , Male , Mental Disorders/epidemiology , Middle Aged , Obesity/epidemiology , Odds Ratio , Prevalence , Severity of Illness Index , Switzerland/epidemiology , Tranquilizing Agents
10.
J Cancer ; 8(10): 1717-1725, 2017.
Article in English | MEDLINE | ID: mdl-28819367

ABSTRACT

Background: Inpatient rehabilitation for cancer patients has been demonstrated to improve patients' health related quality of life (HRQoL) effectively. The purpose of this study was to compare changes in general health and HRQoL of cancer patients who were referred to inpatient rehabilitation (IR) with those in two control groups who underwent outpatient management either with advice for inpatient rehabilitation (A+) or without (A-). Methods: In this naturalistic, longitudinal, controlled cohort study, changes in general health and HRQoL were assessed at either discharge of acute hospital or start of rehabilitation (baseline) and at the follow-up 3 weeks later or end of rehabilitation. Outcome variables included general health and HRQoL assessed by the Short Form 36 (SF-36) and the Functional Assessment of Cancer Therapy (FACT), and fatigue (FACT-F), depression and anxiety by the Hospital Anxiety and Depression Scale (HADS). Changes on the scores were compared with bivariate and multivariate analyses using standardized mean differences (SMD). Results: IR patients (n=133) were on average older, reported lower HRQoL and health, and suffered more frequently from carcinoma than patients of the A+ (n=30) and the A- (n=82) groups. In the IR patients, pain, physical functioning, mental health, vitality, and fatigue improved significantly compared to the A+ controls. Compared to the A- group, the bivariate effects were lower but still statistically significant on many scales. Conclusions: IR showed moderate, statistically significant superior effects over outpatient management of cancer patients after acute treatment. Findings indicate that inpatient cancer rehabilitation can be recommended as an effective management after acute treatment. As today, referrals to inpatient rehabilitation for cancer patients are still not based on structured standardized procedures, the implementation of such screening is needed to address patients' needs and to render the potential for rehabilitation more reliable.

11.
Medicine (Baltimore) ; 96(9): e6113, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28248865

ABSTRACT

Whiplash injury associated disorders (WAD) cause high costs for public health care. Neck pain is number 16 on the global prevalence lists for the 50 most common sequelae. It is of importance to obtain long-term data on disability and working capacity outcomes after rehabilitation. Long-term prospective data of the outcome course of whiplash are sparse. The aim of this study was to quantify improvements of pain, function/role performance, vitality, and working capacity 5 years after whiplash injury and to compare the state of health to normative values at 5 years after rehabilitation.In this naturalistic, observational, prospective cohort study, 115 patients were assessed 5 years (60 months) after a multidisciplinary rehabilitation program. The assessment set consisted of the Short Form 36 (SF-36), parts of the North American Spine Society's cervical spine assessment questionnaire (NASS) and the coping strategies questionnaire (CSQ). The effects were quantified by effect size (ES) and standardized response mean (SRM). Score differences over the course were tested by the Wilcoxon-Mann-Whitney U test for significance.Comparing data between entry and 60 months after rehabilitation 8 of 15 parameters improved with large ES/SRM. Outcome between 6 and 60 months showed small to moderate ES/SRM. Working capacity increased from 0 at entry to rehabilitation to 21 h/wk at 6 months and to 30 h/wk at 60 months follow-up.After large improvements in health and working capacity in the mid-term, further important improvements were observed in the long-term course. It can be hypothesized that part of those can be attributed to the interventions during inpatient rehabilitation, for example, due to better coping strategies.


Subject(s)
Whiplash Injuries/rehabilitation , Adult , Female , Follow-Up Studies , Humans , Male , Middle Aged , Physical Therapy Modalities , Prospective Studies , Recovery of Function , Work Capacity Evaluation
13.
Medicine (Baltimore) ; 96(47): e8493, 2017 Nov.
Article in English | MEDLINE | ID: mdl-29381924

ABSTRACT

The aim of this pilot study was to determine health-related quality of life (HRQoL) in patients with history of medication overuse headache (MOH) after detoxification and a headache-specific inpatient rehabilitation program and to receive necessary information for future prospective studies.HRQoL and headache-related disability were cross-sectionally measured by Short Form 36 (SF-36), Hospital Anxiety and Depression Scale (HADS), Migraine Disability Score (MIDAS), Coping Strategies Questionnaire (CSQ), and Symptom Checklist 90 revised (SCL-90-R). SF-36, HADS, and SCL-90-R data were compared to German population norms, stratified by age, sex, and comorbidities.Fifty-one patients (72.5% females, mean age 47.3 years) were included with an average headache duration of 25.3 years. Moderate to high levels of headache were reported on the MIDAS VAS at 6.51 (range 0-10); SF-36 bodily pain was 40.3 (norm = 59.0, P < .001, 100 = best). Impaired functioning averaged at 78.4 (100 = no impairment) on the MIDAS. In contrast, SF-36 physical functioning was comparable to the norm (mean: 78.4, norm = 81.8, P = .63). All other SF-36 scales were significantly lower than expected from the norm (all P < .001). The scales depression, anxiety, obsessive-compulsive, and interpersonal sensitivity were significantly affected, whereas the levels of SCL-90-R schizophrenia nuclear and schizotypia were not lower than the norm. Coping with pain was moderate.This pilot study is the first that presents a comprehensive and simultaneously specific assessment of health and quality of life of MOH patients after detoxification and inpatient rehabilitation. Moderate to high levels of pain and self-reported disability owing to headache were observed, whereas physical function on the SF-36 was not different from the expected level of the norm. Mental health was substantially affected in several dimensions, which had been described to reduce the ability to cope with pain. MOH patients seem to have high expectations of functionality, low symptomatology, and intact well-being.


Subject(s)
Headache Disorders, Secondary/rehabilitation , Health Status , Mental Health , Quality of Life , Adaptation, Psychological , Adult , Age Factors , Comorbidity , Cross-Sectional Studies , Female , Germany , Headache Disorders, Secondary/psychology , Humans , Male , Middle Aged , Pain Measurement , Pilot Projects , Prospective Studies , Sex Factors
14.
J Clin Epidemiol ; 82: 128-136, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27986610

ABSTRACT

OBJECTIVE: To illustrate and discuss current and proposed new concepts of effect size (ES) quantification and significance, with a focus on statistical and clinical/subjective interpretation and supported by empirical examples. STUDY DESIGN AND SETTINGS: Different methods for determining minimal clinically important differences (MCIDs) are reviewed, applied to practical examples (pain score differences in knee osteoarthritis), and further developed. Their characteristics, advantages, and disadvantages are illustrated and discussed. RESULTS: Empirical score differences between verum and placebo become statistically significant if sample sizes are sufficiently large. MCIDs, by contrast, are defined by patients' perceptions. MCIDs obtained by the most common "mean change method" can be expressed as absolute or relative scores, as different ES parameters, and as the optimal cutoff point on the receiver operating characteristic curve. They can further be modeled by linear and logistic regression, adjusting for potential confounders. CONCLUSION: Absolute and relative MCIDs are easy to interpret and apply to data of investigative studies. MCIDs expressed as effect sizes reduce bias, which mainly results from dependency on the baseline score. Multivariate linear and logistic regression modeling further reduces bias. Anchor-based methods use clinical/subjective perception to define MCIDs and should be clearly differentiated from distribution-based methods that provide statistical significance only.


Subject(s)
Epidemiologic Studies , Minimal Clinically Important Difference , Biometry , Humans , ROC Curve , Sample Size , Surveys and Questionnaires
16.
Swiss Med Wkly ; 145: w14214, 2015.
Article in English | MEDLINE | ID: mdl-26636479

ABSTRACT

QUESTION UNDER STUDY: Rehabilitation for cancer patients aims to reduce physical disability and mental distress resulting from the disease and its treatment. However, little is known about the use of cancer inpatient rehabilitation in Switzerland in relation to sociodemographic and medical characteristics. The main purpose of this study was to evaluate whether there are differences in sociodemographic and medical characteristics between patients who underwent inpatient rehabilitation (users) and those who did not (nonusers). METHODS: A total of 238 cancer patients from the University Hospital Zurich were included. The sociodemographic and medical characteristics of inpatient rehabilitation users were assessed and compared with those of nonusers. We analysed the differences between inpatient rehabilitation users and nonusers. RESULTS: Of the patients included, 101 (42.4%) used inpatient rehabilitation. They were less likely to be employed (p = 0.029), stayed longer in hospital (p <0.001), and were more likely to have semiprivate or private supplementary health insurance (p = 0.030) than nonusers. There were differences in cancer site (p = 0.001). Patients with tumours of the digestive organs or of the thoracic organs were more likely to use rehabilitation, whereas breast cancer patients were less likely to use it. Stratified analyses showed that male patients with semiprivate or private supplementary health insurance (p = 0.037), lower education (p = 0.039), and lower likelihood of employment (p = 0.051) were more likely to use rehabilitation. Women with an advanced tumour stage used inpatient rehabilitation more often (p = 0.012). CONCLUSIONS: Findings show the influence of duration of hospitalisation, insurance type, cancer site, employment status, and gender on the use of inpatient cancer rehabilitation. The results indicate the need of structured standardised procedures for medical referral to be implemented based on screening.


Subject(s)
Employment , Hospitalization/statistics & numerical data , Inpatients/statistics & numerical data , Neoplasms/classification , Neoplasms/rehabilitation , Adult , Aged , Aged, 80 and over , Female , Humans , Insurance, Health , Male , Middle Aged , Neoplasms/economics , Switzerland , Young Adult
17.
BMC Musculoskelet Disord ; 16: 340, 2015 Nov 06.
Article in English | MEDLINE | ID: mdl-26546050

ABSTRACT

BACKGROUND: The m. quadriceps femoris is the strongest muscle in the human body and plays an important role in sports, activities of daily living and independence. Two older studies showed increased electromyographic (EMG) activity of the quadriceps when the dorsal extensors of the foot were pre-activated. The aim was to physiologically replicate this finding by EMG and to verify it functionally by single leg hop. METHODS: EMG activity (root mean square, RMS) was tested on the leg press at the isometric load of the individual 12-repetition-maximum (12RM) weight (on average 79.7 kg) at 45° and 90° knee flexion. Single leg hop distance was measured between the tests. Intra-individual changes between with and without dorsal foot extension were quantified and compared by standardized response means (SRM). RESULTS: Thirty-five healthy subjects between 21 and 57 years were included. The m. vastus medialis was activated on average to an RMS of 32.4 µV without and 53.7 µV with dorsal foot extension (SRM = 1.39, p < 0.001) at 45° knee flexion and an RMS of 124.9 µV versus 152.8 µV (SRM = 1.08, p < 0.001) at 90°. The corresponding data for the rectus femoris were 9.4 µV versus 18.9 µV (SRM = 0.71, p < 0.001) at 45° and 77.8 µV versus 135.3 µV (SRM = 0.89, p < 0.001) at 90°. Mean single leg hop distance was 169.8 cm without versus 178.9 cm with dorsal foot extension (SRM = 1.09, p < 0.001). CONCLUSIONS: Pre-activation of dorsal foot extensors significantly increased EMG activity in the m. quadriceps femoris and single leg hop distance. It can therefore be used to improve functional quadriceps muscle performance and knee joint stability in training and rehabilitation.


Subject(s)
Foot/physiology , Muscle Contraction , Quadriceps Muscle/physiology , Adult , Biomechanical Phenomena , Cohort Studies , Cross-Sectional Studies , Electromyography , Female , Healthy Volunteers , Humans , Knee Joint/physiology , Male , Middle Aged , Muscle Strength , Pilot Projects , Young Adult
18.
Vasa ; 44(2): 129-37, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25698391

ABSTRACT

BACKGROUND: Little is known about comprehensively measured health and quality of life of lower limb lymphedema (LLL). The aim of this study was to determine health and quality of life of LLL patients stratified by primary and secondary lymphedema compared to a normative population-based data stratified by age, sex and comorbidity. PATIENTS AND METHODS: A cross-sectional study of patients after treatment at the department of angiology of a rehabilitation clinic was conducted. Self-assessment was performed by the Short Form 36 (SF-36) and two condition-specific measures. RESULTS: Primary LLL (n = 52) 75 % female, mean age 47.1 years) reported health comparable to normative values, e. g. SF-36 physical functioning 80.4 (norm 84.1, p = 0.512) and SF-36 vitality 62.7 (59.7, p = 0.117) (mean scores, 100 = best). Secondary LLL (n = 60, 68 % female, mean age 60.6 years) scored 68.1 (73.9, p = 0.049) and 55.2 (56.2, p = 0.800) on the corresponding scales. Mean symptoms and function scores on the specific measures ranged from 70.0 to 83.1 for primary LLL (100 = best) and from 63.3 to 80.6 for secondary LLL. Function, vitality and both SF-36 role dimensions were higher in primary LLL than in secondary LLL, (mean SF-36 vitality 62.7 versus 55.2, p = 0.035). CONCLUSIONS: Overall health and quality of life was high and comparable to the general population norms in primary LLL. The same was true for most psycho-social scales in secondary LLL whereas functionally some deficits were recorded. Cancer as the most frequent cause for secondary LLL may affect health in these dimensions. Reported negative effects of LLL seem to be well compensated, especially in primary LLL and under optimal treatment.


Subject(s)
Health Status Indicators , Health Status , Lower Extremity/physiopathology , Lymphedema/diagnosis , Quality of Life , Surveys and Questionnaires , Case-Control Studies , Cross-Sectional Studies , Female , Humans , Lymphedema/etiology , Lymphedema/physiopathology , Lymphedema/psychology , Lymphedema/therapy , Male , Middle Aged , Predictive Value of Tests , Risk Factors , Severity of Illness Index , Treatment Outcome
19.
Swiss Med Wkly ; 144: w14004, 2014.
Article in English | MEDLINE | ID: mdl-25184941

ABSTRACT

OBJECTIVE: To compare general health and the health-related quality of life of patients admitted to inpatient rehabilitation after a stay in an acute hospital before and after the introduction of Swiss Diagnosis Related Groups (SwissDRG). METHODS: Consecutively referred patients with disorders of the lower extremities (LEX) or lumbar spine (LS) were evaluated by standardised outcome assessment instruments and for various co-factors. State (at entry to rehabilitation) and change of health (between entry and discharge from rehabilitation) were then compared between the cohorts before and after introduction of SwissDRG. RESULTS: In LEX (n = 234), state of health, measured by the instruments' scores at entry, was not significantly different before and after SwissDRG, except for emotional role (worse state after SwissDRG, p = 0.021). These results were consistent for the LS group (n = 161). Change of health from entry to dismissal was comparable before and after DRG in the LEX group, whereas in the LS group, improvements after SwissDRG were significantly smaller in physical role (p = 0.042), bodily pain (p = 0.012) and physical component summary (p = 0.009) than before SwissDRG. Duration of stay in an acute hospital and duration of stay in the rehabilitation clinic were comparable before and after SwissDRG in both groups. CONCLUSIONS: While state of health was comparable in both diagnostic groups, some dimensions in the LS group revealed lesser improvements after introduction of SwissDRG compared to before. In analogy to long-term observations after the introduction of DRG in Germany, it is possible that greater differences will also be identified in Switzerland by future studies.


Subject(s)
Diagnosis-Related Groups , Health Status , Musculoskeletal Diseases/rehabilitation , Quality of Life , Adult , Aged , Aged, 80 and over , Female , Humans , Length of Stay , Lower Extremity , Lumbosacral Region , Male , Middle Aged , Musculoskeletal Diseases/psychology , Musculoskeletal Diseases/surgery , Musculoskeletal Pain/etiology , Pain Measurement , Prospective Studies , Surveys and Questionnaires , Switzerland
20.
Rev Med Suisse ; 10(436): 1382-6, 2014 Jun 25.
Article in French | MEDLINE | ID: mdl-25055471

ABSTRACT

From the point of view of the rheumatologist, the treatment of pain should be adjusted individually in accordance with medical principles based on the facts related to the relevant pathologies. This treatment includes conservative (medicinal and non-medicinal), interventional and surgical methods. The treatment does not just depend on the diagnosis, but also on the particular functional disability based on the ICF (International Classification of Functioning) and the level of polymorbidity. As rheumatology patients often have comorbidity, the choice of painkillers (NSAIDs, analgesics, opioids etc), immunosuppressants and physical therapy methods (physiotherapy, ergotherapy, etc) may be limited.


Subject(s)
Pain Management/methods , Physicians , Rheumatic Diseases/drug therapy , Specialization , Humans , Pain Measurement , Rheumatic Diseases/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...